
Qi Miao | BCM - Baylor College of Medicine
Qi Miao, Vilas D. Kadam, Ayan Mukherjee, Zhi Tan, and Mingxing Teng "Unlocking DCAFs To Catalyze Degrader Development: An Arena for Innovative Approaches." J. Med. Chem. 2023;66(19):13369-13383. Hide 1 publications
Qi Miao - Google Scholar
Qi Miao. St Jude Children's Research Hospital. Verified email at stjude.org. Aging Regeneration Fibrosis Genomics. Articles Cited by Public access. Title. Sort. ... Q Miao, Y Sun, T Wei, X Zhao, K Zhao, L Yan, X Zhang, H Shu, F Yang. Journal of …
Qi Miao - Baylor College of Medicine - LinkedIn
View Qi Miao’s profile on LinkedIn, a professional community of 1 billion members. I’m trained in medicinal chemistry in China Pharmaceutical University for 6 years. Till…
- Connections: 347
- Location: Baylor College of Medicine
Qi Miao - Graduate Research Assistant - MD Anderson Cancer …
• Developed and applied computational methods for high dimensional single-cell data analysis. • Collaborated with oncologists to improve existing cancer treatment and assess...
- Title: PhD candidate in Biostatistics …
- Location: MD Anderson Cancer Center
- Connections: 213
Qi MIAO | PhD | Baylor College of Medicine, TX - ResearchGate
Qi MIAO | Cited by 369 | of Baylor College of Medicine, TX (BCM) | Read 12 publications | Contact Qi MIAO
Miao Qi - Google Scholar
Inside Cover: Enabling Lithium Metal Anode in Nonflammable Phosphate Electrolyte with Electrochemically Induced Chemical Reactions (Angew. Chem. Int. Ed. 35/2021) H Zhang, J Luo, M Qi, S Lin, Q Dong, H Li, N Dulock, C Povinelli, N Wong, ...
Qi MIAO | Doctor of Medicinal chemistry | Baylor College of …
Qi MIAO | Cited by 51 | of Baylor College of Medicine, TX (BCM) | Read 8 publications | Contact Qi MIAO
Qi Miao (0000-0003-2782-1581) - ORCID
Dec 20, 2023 · ORCID record for Qi Miao. ORCID provides an identifier for individuals to use with their name as they engage in research, scholarship, and innovation activities.
Pages - en:Qi_Miao - University of California, Los Angeles
Research Interests – Medical Imaging Research in Prostate and Pancreatic Cancer. Investigating advanced imaging techniques and methodologies for the early detection, diagnosis, and precise staging of prostate and pancreatic cancers, with a focus on improving patient outcomes and treatment strategies. AI Applications in Medical Imaging.
Unlocking DCAFs To Catalyze Degrader Development: An Arena …
Sep 22, 2023 · Here, we endeavor to explore the collaborative efforts involved in unlocking a broad range of CRL4 DCAF for degrader drug development. Throughout the discussion, we also highlight how both conventional and innovative approaches in drug discovery can be taken to realize this objective.
- Some results have been removed